Thu, August 2, 2018
Wed, August 1, 2018
Tue, July 31, 2018
Mon, July 30, 2018
Fri, July 27, 2018
Thu, July 26, 2018
Wed, July 25, 2018
Tue, July 24, 2018

Robyn Karnauskas Maintained (VRTX) at Strong Buy with Increased Target to $206 on, Jul 30th, 2018


//stocks-investing.news-articles.net/content/201 .. th-increased-target-to-206-on-jul-30th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Robyn Karnauskas of Citigroup, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Increased Target from $203 to $206 on, Jul 30th, 2018.

Robyn has made no other calls on VRTX in the last 4 months.



There are 2 other peers that have a rating on VRTX. Out of the 2 peers that are also analyzing VRTX, 1 agrees with Robyn's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Carter Gould of "UBS" Maintained at Hold with Increased Target to $188 on, Thursday, July 26th, 2018


This is the rating of the analyst that currently disagrees with Robyn


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $211 on, Thursday, July 26th, 2018

Publication Contributing Sources